LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $604,000 | -9.6% | 6,066 | +3.7% | 0.67% | -9.5% |
Q2 2019 | $668,000 | -9.7% | 5,848 | -0.7% | 0.74% | -14.1% |
Q1 2019 | $740,000 | -8.4% | 5,889 | -1.1% | 0.86% | -13.3% |
Q4 2018 | $808,000 | -57.4% | 5,955 | -13.8% | 0.99% | -47.0% |
Q3 2018 | $1,895,000 | +33.3% | 6,905 | +0.6% | 1.87% | +18.3% |
Q2 2018 | $1,422,000 | +25.4% | 6,865 | 0.0% | 1.58% | +28.6% |
Q1 2018 | $1,134,000 | +22.6% | 6,865 | +1.6% | 1.23% | +25.8% |
Q4 2017 | $925,000 | -2.4% | 6,755 | -3.0% | 0.98% | -0.8% |
Q3 2017 | $948,000 | – | 6,965 | – | 0.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |